Sabeeh-Ur-Rehman Butt - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sabeeh-Ur-Rehman Butt

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Cancer Chemotherapy and Pharmacology|January 26, 2018

Role of immunotherapy in bladder cancer: past, present and futureSabeeh-Ur-Rehman Butt, Laeeq Malik

Journal of Medical Case Reports|April 21, 2016

Complete heart block in a Caucasian woman with Behçet's disease: a case reportSabeeh-Ur-Rehman Butt, Julian McNeil

Cancer Chemotherapy and Pharmacology|February 4, 2021

BRAF/MEK inhibitors for BRAF V600E-mutant cancers in non-approved setting: a case seriesSabeeh-Ur-Rehman Butt, Alberto Mejias, Cristina Morelli, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Cancer Chemotherapy and Pharmacology|January 26, 2018

Role of immunotherapy in bladder cancer: past, present and futureSabeeh-Ur-Rehman Butt, Laeeq Malik

Journal of Medical Case Reports|April 21, 2016

Complete heart block in a Caucasian woman with Behçet's disease: a case reportSabeeh-Ur-Rehman Butt, Julian McNeil

Cancer Chemotherapy and Pharmacology|February 4, 2021

BRAF/MEK inhibitors for BRAF V600E-mutant cancers in non-approved setting: a case seriesSabeeh-Ur-Rehman Butt, Alberto Mejias, Cristina Morelli, et al.

Pageof 1